Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
McNeil
S A
SA
Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Healthcare System, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
Clark
N M
NM
Chandrasekar
P H
PH
Kauffman
C A
CA
D000081:Acetamides / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy*; D016026:Bone Marrow Transplantation; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016984:Enterococcus faecium / Q000187:drug effects* / Q000302:isolation & purification; D005500:Follow-Up Studies; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000628:therapy; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000008:administration & dosage*; D023303:Oxazolidinones; D011183:Postoperative Complications; D017211:Treatment Failure; D016896:Treatment Outcome; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000627:therapeutic use
D000081:Acetamides; D000900:Anti-Bacterial Agents; D010080:Oxazoles; D023303:Oxazolidinones; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; D000069349:Linezolid